277 related articles for article (PubMed ID: 2694664)
21. Human renal microvascular endothelial cells as a potential target in the development of the hemolytic uremic syndrome as related to fibrinolysis factor expression, in vitro.
Louise CB; Obrig TG
Microvasc Res; 1994 May; 47(3):377-87. PubMed ID: 8084301
[TBL] [Abstract][Full Text] [Related]
22. [Regulation of antithrombogenicity in endothelium by hemodynamic forces].
Kawai Y; Matsumoto Y; Ikeda Y; Watanabe K
Rinsho Byori; 1997 Apr; 45(4):315-20. PubMed ID: 9136594
[TBL] [Abstract][Full Text] [Related]
23. Ethanol transcriptionally upregulates t-PA and u-PA gene expression in cultured human endothelial cells.
Grenett HE; Aikens ML; Torres JA; Demissie S; Tabengwa EM; Davis GC; Booyse FM
Alcohol Clin Exp Res; 1998 Jun; 22(4):849-53. PubMed ID: 9660311
[TBL] [Abstract][Full Text] [Related]
24. [Relationship between plasminogen activator, plasminogen activator inhibitor and Sertoli cells].
Wang XY; Xiong CL
Zhonghua Nan Ke Xue; 2003 Apr; 9(2):133-5, 139. PubMed ID: 12749136
[TBL] [Abstract][Full Text] [Related]
25. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells.
Van Hinsbergh VW; Sprengers ED; Kooistra T
Thromb Haemost; 1987 Apr; 57(2):148-53. PubMed ID: 3496679
[TBL] [Abstract][Full Text] [Related]
26. Plasminogen-dependent and -independent proteolytic activity of murine endothelioma cells with targeted inactivation of fibrinolytic genes.
Lijnen HR; Wagner EF; Collen D
Thromb Haemost; 1997 Feb; 77(2):362-7. PubMed ID: 9157597
[TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor induces the production of urokinase-type plasminogen activator by human endothelial cells.
van Hinsbergh VW; van den Berg EA; Fiers W; Dooijewaard G
Blood; 1990 May; 75(10):1991-8. PubMed ID: 2140060
[TBL] [Abstract][Full Text] [Related]
28. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
Siegbahn A; Ruusuvaara L
Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
[TBL] [Abstract][Full Text] [Related]
29. Vascular smooth muscle cells inhibit the plasminogen activators secreted by endothelial cells.
Laug WE
Thromb Haemost; 1985 Apr; 53(2):165-9. PubMed ID: 3927503
[TBL] [Abstract][Full Text] [Related]
30. Detection of both type 1 and type 2 plasminogen activator inhibitors in human cells.
Schleef RR; Wagner NV; Loskutoff DJ
J Cell Physiol; 1988 Feb; 134(2):269-74. PubMed ID: 3257967
[TBL] [Abstract][Full Text] [Related]
31. The urokinase-type plasminogen activator, its receptor and u-PA inhibitor type-1 affect in vitro growth and invasion of Kaposi's sarcoma and capillary endothelial cells: role of HIV-Tat protein.
Margheri F; D'Alessio S; Serratì S; Pucci M; Del Rosso A; Benelli R; Ferrari N; Noonan DM; Albini A; Fibbi G; Del Rosso M
Int J Oncol; 2005 Jul; 27(1):223-35. PubMed ID: 15942664
[TBL] [Abstract][Full Text] [Related]
32. Endothelial cell activation in cutaneous vasculitis.
Jurd KM; Stephens CJ; Black MM; Hunt BJ
Clin Exp Dermatol; 1996 Jan; 21(1):28-32. PubMed ID: 8689765
[TBL] [Abstract][Full Text] [Related]
33. Alcohol-induced upregulation of plasminogen activators and fibrinolytic activity in cultured human endothelial cells.
Aikens ML; Grenett HE; Benza RL; Tabengwa EM; Davis GC; Booyse FM
Alcohol Clin Exp Res; 1998 Apr; 22(2):375-81. PubMed ID: 9581643
[TBL] [Abstract][Full Text] [Related]
34. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Collen D; Lijnen HR
Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
[TBL] [Abstract][Full Text] [Related]
35. Occurrence of components of fibrinolytic pathways in situ in laryngeal cancer.
Wojtukiewicz MZ; Sierko E; Zacharski LR; Rózanska-Kudelska M; Zimnoch L
Semin Thromb Hemost; 2003 Jun; 29(3):317-20. PubMed ID: 12888936
[TBL] [Abstract][Full Text] [Related]
36. [Type 1 plasminogen activator inhibitor: its role in biological reactions].
Mimuro J
Rinsho Ketsueki; 1991 May; 32(5):487-9. PubMed ID: 1870265
[TBL] [Abstract][Full Text] [Related]
37. [Plasminogen activator inhibitors].
Swiatkowska M; Wilczyńska M; Cierniewski CS
Postepy Biochem; 1991; 37(3-4):139-45. PubMed ID: 1812471
[No Abstract] [Full Text] [Related]
38. [The regulation of blood coagulation and fibrinolysis by vascular endothelial cells].
Nishimura H; Tsuji H; Yoshizumi M; Nakagawa M
Nihon Rinsho; 1999 Jul; 57(7):1492-6. PubMed ID: 10429446
[TBL] [Abstract][Full Text] [Related]
39. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells.
van Hinsbergh VW; Kooistra T; Scheffer MA; Hajo van Bockel J; van Muijen GN
Blood; 1990 Apr; 75(7):1490-7. PubMed ID: 2107884
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor-1 in microvascular endothelial cells.
Pepper MS; Ferrara N; Orci L; Montesano R
Biochem Biophys Res Commun; 1991 Dec; 181(2):902-6. PubMed ID: 1755866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
